These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29169459)
1. Production of Neoepitopes by Dynamic Structural Changes on BP180/Type XVII Collagen. Hashimoto T; Ishii N; Tsuruta D J Invest Dermatol; 2017 Dec; 137(12):2462-2464. PubMed ID: 29169459 [TBL] [Abstract][Full Text] [Related]
2. C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies. Toyonaga E; Nishie W; Izumi K; Natsuga K; Ujiie H; Iwata H; Yamagami J; Hirako Y; Sawamura D; Fujimoto W; Shimizu H J Invest Dermatol; 2017 Dec; 137(12):2552-2559. PubMed ID: 28842325 [TBL] [Abstract][Full Text] [Related]
3. Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180. Yamauchi T; Matsushita S; Hashimoto T; Hirako Y J Dermatol Sci; 2014 Oct; 76(1):25-33. PubMed ID: 25176590 [TBL] [Abstract][Full Text] [Related]
4. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180. Tashima S; Konishi K; Koga H; Hashimoto T Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415 [No Abstract] [Full Text] [Related]
5. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735 [TBL] [Abstract][Full Text] [Related]
6. IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180. Nie Z; Nagata Y; Joubeh S; Hirako Y; Owaribe K; Kitajima Y; Hashimoto T J Invest Dermatol; 2000 Dec; 115(6):1164-6. PubMed ID: 11121162 [No Abstract] [Full Text] [Related]
7. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397 [TBL] [Abstract][Full Text] [Related]
8. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease. Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223 [TBL] [Abstract][Full Text] [Related]
9. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070 [TBL] [Abstract][Full Text] [Related]
10. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772 [TBL] [Abstract][Full Text] [Related]
11. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Powell AM; Sakuma-Oyama Y; Oyama N; Black MM Clin Exp Dermatol; 2005 Nov; 30(6):682-7. PubMed ID: 16197389 [TBL] [Abstract][Full Text] [Related]
12. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. Fairley JA; Fu CL; Giudice GJ J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787 [TBL] [Abstract][Full Text] [Related]
13. Case of subepidermal bullous disease with diffuse esophageal involvement presenting with immunoglobulin G autoantibodies to both the BP180 NC16a and C-terminal domains, and immunoglobulin A autoantibodies to the BP180 NC16a domain. Takayama N; Nakazono S; Kumagai J; Kawamura T; Suzuki F; Ishii N; Hashimoto T; Namiki T J Dermatol; 2014 Jul; 41(7):665-7. PubMed ID: 24930476 [No Abstract] [Full Text] [Related]
14. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97. Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718 [TBL] [Abstract][Full Text] [Related]
16. The NC16A domain of collagen XVII plays a role in triple helix assembly and stability. Van den Bergh F; Fu CL; Olague-Marchan M; Giudice GJ Biochem Biophys Res Commun; 2006 Dec; 350(4):1032-7. PubMed ID: 17045967 [TBL] [Abstract][Full Text] [Related]
17. Linear IgA Bullous Dermatosis in a Pregnant Woman with Autoantibodies to the Non-collagenous 16A Domain of Type XVII Collagen. Matsuura K; Ujiie H; Hayashi M; Muramatsu K; Yoshizawa J; Ito T; Iwata H; Suzuki T; Shimizu H Acta Derm Venereol; 2017 Mar; 97(3):404-405. PubMed ID: 27786348 [No Abstract] [Full Text] [Related]
18. Linear IgA/IgG bullous dermatosis with autoantibodies directing the native and processed forms of BP180. Inamura E; Nishie W; Yamaguchi Y; Fujimura Y; Ujiie H; Natsuga K; Shimizu H Br J Dermatol; 2020 Apr; 182(4):1061-1062. PubMed ID: 31675432 [No Abstract] [Full Text] [Related]
19. IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a patient with linear IgA disease. Ishii N; Ohyama B; Yamaguchi Z; Hashimoto T Br J Dermatol; 2008 May; 158(5):1151-3. PubMed ID: 18363761 [No Abstract] [Full Text] [Related]
20. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid. Nishie W; Lamer S; Schlosser A; Licarete E; Franzke CW; Hofmann SC; Jackow J; Sitaru C; Bruckner-Tuderman L J Immunol; 2010 Oct; 185(8):4938-47. PubMed ID: 20861347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]